SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION
12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR
SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND
15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 0-18241
BARRINGER LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
15000 W. 6TH, SUITE 300
GOLDEN, COLORADO 80401
(303) 277-1687
(Address, including zip code, and telephone number, including area
code, of registrant's principal executive offices)
COMMON STOCK, $.01 PAR VALUE
(Title of each class of securities covered by this Form)
NONE
(Title of all other classes of securities for which a duty to file
reports under Section 13(a) or 15(d) remains)
Please place an "X" in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6
Rule 12h-3(b)(1)(i) [X]
APPROXIMATE NUMBER OF HOLDERS OF RECORD AS OF THE CERTIFICATION OR NOTICE
DATE: NINETY-NINE (99).
Pursuant to the requirements of the Securities Exchange Act of 1934,
Barringer Laboratories, Inc., has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized person.
DATE: August 11, 2000
BARRINGER LABORATORIES, INC.
By: /s/ Graham Russell
-----------------------------------
Graham Russell
Chief Executive Officer
